AGPAT2

Chr 9AR

1-acylglycerol-3-phosphate O-acyltransferase 2

Also known as: 1-AGPAT2, BSCL, BSCL1, LPAAB, LPAAT-beta, LPLAT2

This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]

Primary Disease Associations & Inheritance

Lipodystrophy, congenital generalized, type 1MIM #608594
AR
2
Active trials
105
Pathogenic / LP
362
ClinVar variants
4
Pubs (1 yr)
-0.7
Missense Z
1.54
LOEUF
Clinical SummaryAGPAT2
🧬
Gene-Disease Validity (ClinGen)
lipodystrophy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
105 Pathogenic / Likely Pathogenic· 150 VUS of 362 total submissions
💊
Clinical Trials
2 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — AGPAT2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
1.54LOEUF
pLI 0.000
Z-score 0.20
OE 0.94 (0.591.54)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
-0.72Z-score
OE missense 1.15 (1.031.30)
199 obs / 172.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.94 (0.591.54)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.1.15 (1.031.30)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.22
01.21.6
LoF obs/exp: 11 / 11.7Missense obs/exp: 199 / 172.3Syn Z: -1.51

ClinVar Variant Classifications

362 submitted variants in ClinVar

Classification Summary

Pathogenic86
Likely Pathogenic19
VUS150
Likely Benign65
Benign19
Conflicting23
86
Pathogenic
19
Likely Pathogenic
150
VUS
65
Likely Benign
19
Benign
23
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
8
4
74
0
86
Likely Pathogenic
12
2
5
0
19
VUS
2
100
41
7
150
Likely Benign
0
5
28
32
65
Benign
0
1
17
1
19
Conflicting
23
Total2211216540362

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

AGPAT2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

AGPAT2-related lipodystrophy, congenital generalised

definitive
ARLoss Of FunctionAbsent Gene Product
Skin
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Literature
Landmark / reviewRecent case evidence